journal article·2023-01-01

Modular assembly of bioprinted perfusable blood vessel and tracheal epithelium for studying inflammatory respiratory diseases

Hyoryung Nam, Yoo-mi Choi, Sungkeon Cho, Ge Gao, Donghwan Kim, Jongmin Kim, Hwanyong Choi, Se-Hwan Lee, Jinah Jang

Biofabrication· Volume 15· Issue 1
Publisher page

Abstract

Abstract In vitro organ models allow for the creation of precise preclinical models that mimic organ physiology. During a pandemic of a life-threatening acute respiratory disease, an improved trachea model (TM) is required. We fabricated a modular assembly of the blood vessel and TMs using 3D bioprinting technology. First, decellularized extracellular matrix (dECM) were prepared using the porcine trachea and blood vessels. A trachea module was fabricated based on the tracheal mucosa-derived dECM and microporous membrane. Further, a blood vessel module was manufactured using the prepared vascular-tissue-derived dECM. By assembling each manufactured module, a perfusable vascularized TM simulating the interface between the tracheal epithelium and blood vessels was fabricated. This assembled model was manufactured with efficient performance, and it offered respiratory symptoms, such as inflammatory response and allergen-induced asthma exacerbation. These characteristics indicate the possibility of manufacturing a highly functional organ model that mimics a complex organ environment in the future.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Innovative Microfluidic and Catalytic Techniques Innovation · Cancer Cells and Metastasis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (53)

Show source-provided references
1. External environmental pollution as a risk factor for asthma10.1007/s12016-020-08830-5 ↗
2. Environmental factors in epithelial barrier dysfunction10.1016/j.jaci.2020.04.024 ↗
3. Air pollution and noncommunicable diseases10.1016/j.chest.2018.10.041 ↗
4. Characteristics of SARS-CoV-2 and COVID-1910.1038/s41579-020-00459-7 ↗
5. Global burden of chronic respiratory diseases10.1089/jamp.2019.1576 ↗
6. Modern approaches to understanding stress and disease susceptibility: a review with special emphasis on respiratory disease10.2147/IJGM.S4843 ↗
7. Sheep as a model species for the study and treatment of human asthma and other respiratory diseases10.1016/j.ddmod.2009.12.002 ↗
8. Studying human respiratory disease in animals—role of induced and naturally occurring models10.1002/path.4658 ↗
9. Murine models of hapten-induced asthma10.1016/j.tox.2018.09.001 ↗
10. Small and large animal models in cardiac contraction research: advantages and disadvantages10.1016/j.pharmthera.2013.10.007 ↗
11. Mimicking antigen-driven asthma in rodent models—how close can we get?10.3389/fimmu.2020.575936 ↗
12. Human in vitro vascularized micro-organ and micro-tumor models are reproducible organ-on-a-chip platforms for studies of anticancer drugs10.1016/j.tox.2020.152601 ↗
13. Toward improved in vitro models of human cancer10.1063/5.0026857 ↗
14. Airway remodeling in asthma10.3389/fmed.2020.00191 ↗
15. Trachea: anatomy and physiology10.1016/j.thorsurg.2013.09.004 ↗
16. Vascularized lower respiratory-physiology-on-a-chip10.3390/app10030900 ↗
17. The blood–brain barrier10.1101/cshperspect.a020412 ↗
18. 3D bioprinting-based vascularized tissue models mimicking tissue-specific architecture and pathophysiology for in vitro studies10.3389/fbioe.2021.685507 ↗
19. Pulmonary edema: pathophysiology and diagnosis
20. Pulmonary hypertension in COPD10.1183/09031936.00015608 ↗
21. Pulmonary hypertension in chronic obstructive pulmonary disease10.1183/09031936.03.00115402 ↗
22. The role of the bronchial microvasculature in the airway remodelling in asthma and COPD10.1186/1465-9921-11-132 ↗
23. Airway remodeling contributes to the progressive loss of lung function in asthma: an overview10.1016/j.jaci.2005.07.011 ↗
24. Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL-12) and Th cytokines (IFN- γ, IL-4, IL-10 and IL-13) in patients with allergic asthma10.1046/j.1365-2249.2001.01602.x ↗
25. Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro10.1038/nmeth.3697 ↗
26. Development of a functional airway-on-a-chip by 3D cell printing10.1088/1758-5090/aae545 ↗
27. Tissue engineered bio-blood-vessels constructed using a tissue-specific bioink and 3D coaxial cell printing technique: a novel therapy for ischemic disease10.1002/adfm.201700798 ↗
28. Coaxial cell printing of freestanding, perfusable, and functional in vitro vascular models for recapitulation of native vascular endothelium pathophysiology10.1002/adhm.201801102 ↗
29. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink10.1038/ncomms4935 ↗
30. 3D bioprinting technologies and bioinks for therapeutic and tissue engineering applications10.2217/3dp-2018-0014 ↗
31. Decellularized extracellular matrix: a step towards the next generation source for bioink manufacturing10.1088/1758-5090/aa7e98 ↗
32. Characterization of cornea-specific bioink: high transparency, improved in vivo safety10.1177/2041731418823382 ↗
33. Surfactant protein-a protects against IL-13–induced inflammation in asthma10.4049/jimmunol.1901227 ↗
34. Barrier function of airway tract epithelium10.4161/tisb.24997 ↗
35. Epithelial barrier hypothesis and the development of allergic and autoimmune diseases10.1007/s40629-022-00211-y ↗
36. Multi-layered free-form 3D cell-printed tubular construct with decellularized inner and outer esophageal tissue-derived bioinks10.1038/s41598-020-64049-6 ↗
37. 3D cell printing of in vitro stabilized skin model and in vivo pre-vascularized skin patch using tissue-specific extracellular matrix bioink: a step towards advanced skin tissue engineering10.1016/j.biomaterials.2018.03.040 ↗
38. The vascular system: An overview of structure and function10.1016/S1056-8719(00)00125-8 ↗
39. Airway mucus and asthma: the role of MUC5AC and MUC5B10.3390/jcm6120112 ↗
40. Human airway smooth muscle cells express and release RANTES in response to T helper 1 cytokines: regulation by T helper 2 cytokines and corticosteroids10.4049/jimmunol.158.4.1841 ↗
41. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine10.1084/jem.179.2.751 ↗
42. Expression of RANTES by normal airway epithelial cells after influenza virus a infection10.1165/ajrcmb.18.2.2822 ↗
43. TNF-α disrupts the integrity of the porcine respiratory epithelial barrier10.1016/j.rvsc.2019.01.029 ↗
44. Respiratory allergy caused by house dust mites: what do we really know?10.1016/j.jaci.2014.10.012 ↗
45. Association between house dust mites sensitization and level of asthma control and severity in children attending Mansoura university children’s hospital10.1186/s43168-021-00082-x ↗
46. Peripheral blood T cells and neutrophils from asthma patients express class-I MHC-restricted T cell-associated molecule10.1186/1710-1492-10-46 ↗
47. CFTR modulator therapy enhances peripheral blood monocyte contributions to immune responses in people with cystic fibrosis10.3389/fphar.2020.01219 ↗
48. Eosinophil-derived chemokine (hCCL15/23, mCCL6) interacts with CCR1 to promote eosinophilic airway inflammation10.1038/s41392-021-00482-x ↗
49. Immune cell migration in inflammation: present and future therapeutic targets10.1038/ni1275 ↗
50. Eosinophil granule proteins: form and function10.1074/jbc.R113.546218 ↗
51. Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates10.1172/JCI115155 ↗
52. The emerging role of eosinophils as multifunctional leukocytes in health and disease10.4110/in.2020.20.e24 ↗
53. 3D bioprinting strategies for the regeneration of functional tubular tissues and organs10.3390/bioengineering7020032 ↗